Research Symposium

The Department of Internal Medicine Annual Research Symposium showcases the research projects completed by our residents and provides an opportunity for fellows and students, as well as faculty, to present their work and interact with department members. A focal event of the symposium is Grand Rounds delivered by an invited outstanding physician scientist.

2022 Research Symposium, May 5-6

The 2022 Department of Internal Medicine Research Symposium was a great success. 

Welcome Address

“Mitigating COVID-19 Pandemic Impact on Medical Research”
Lisa A. Prosser, PhD
Marilyn Fisher Blanch Research Professor of Pediatrics
Professor & Director, Susan B. Meister Child Health Evaluation and Research Center
Professor, Department of Health Management and Policy, School of Public Health
Associate Vice President for Research-Health Sciences, University of Michigan Office of Research

Ground Rounds Keynote Address

“Pancreatic Cancer: Model Systems, Genetics and Clinical Medicine”
Anil K. Rustgi, MD
Irving Professor of Medicine
Director, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Chief of Cancer Services, New York Presbyterian Hospital

Plenary Oral Presentations

• Targeting NNMT as a Novel Metabolic Approach to Treat Systemic Sclerosis - M.Asif Amin, MBBS
• Serial Monitoring of Single-Cell Circulating Tumor Cell Genomics in Metastatic Lobular Breast Cancer to Identify Precision and Immuno-Oncology Biomarkers With Therapeutic Implications - Andi Cani, PhD
• Trehalose-6-Phosphate Synthase (tps1) in Cryptococcus Neoformans Contributes to Fungal Clearance in the Lungs by the Innate Immune System Through Neutrophils – Kristie Goughenour, PhD
• Clinical Testing Can be Used as a Surrogate for Viral Neutralization to SARS-CoV-2 - Kelly O'Shea, MD
• Identifying Predictors of Immune-Checkpoint Inhibitor Myocarditis - Alexi Vasbinder, PhD, RN
• Food Insecurity Among Cardiology Patients at the University of Michigan – Eric Brandt, MD, MHS
• EZH2 T367 Phosphorylation Activates P38 Signaling Through Lysine Methylation to Promote Breast Cancer Progression – Talha Anwar, MD, PhD
• Plasma Proteomic Signatures in Juvenile Dermatomyositis Define Novel Differentially Regulated Proteins in Treatment Naïve Patients - Marianne Kerski, MD
• Medicare Advantage Plan Double Bonuses Drive Racial Disparity in Payments, Yield No Quality or Enrollment Improvements- Adam Markovitz, MD
• Aspirin Use for the Secondary Prevention of Cardiovascular Disease in Low- and Middle-Income Countries: A Cross-Sectional Study of Individual-Level Data from 40 Nationally Representative Surveys - Sang Gune Yoo, MD
• Closing Remarks | Department of Internal Medicine Benjamin Margolis MD Outstanding Abstract Award

2022 Ben Margolis Research Award Winner

Kelly O'Shea, MD

Kelly O'Shea, MD

Kelly O’Shea, MD is a Clinical Assistant Professor in the Division of Allergy and Clinical Immunology and within the Mary H. Weiser Food Allergy Center. Dr. O'Shea received her medical degree from McGovern Medical School in Houston and then completed her Pediatric residency at Cincinnati Children’s Hospital. Prior to completing her Allergy and Clinical Immunology fellowship at Michigan Medicine, Dr. O'Shea served as clinical faculty in the Department of Pediatrics. Dr. O’Shea’s research and clinical interests lie in food allergy; specifically developing new diagnostic tools and novel treatments for food allergy, as well as oral immunotherapy for food allergy.